Nu Skin Enterprises, Inc. (NYSE:NUS) CFO Mark H. Lawrence sold 724 shares of the business’s stock in a transaction dated Friday, March 9th. The stock was sold at an average price of $72.86, for a total value of $52,750.64. Following the completion of the transaction, the chief financial officer now directly owns 11,473 shares of the company’s stock, valued at approximately $835,922.78. The sale was disclosed in a legal filing with the SEC, which is accessible through this hyperlink.
Nu Skin Enterprises, Inc. (NYSE:NUS) traded up $1.68 during trading on Monday, hitting $74.07. The company’s stock had a trading volume of 581,428 shares, compared to its average volume of 469,724. The company has a market cap of $3,900.00, a P/E ratio of 23.00, a P/E/G ratio of 2.01 and a beta of 1.43. Nu Skin Enterprises, Inc. has a 1-year low of $48.72 and a 1-year high of $74.45. The company has a current ratio of 1.74, a quick ratio of 1.17 and a debt-to-equity ratio of 0.44.
Nu Skin Enterprises (NYSE:NUS) last released its quarterly earnings results on Thursday, February 15th. The company reported $1.20 earnings per share (EPS) for the quarter, beating the Zacks’ consensus estimate of $1.19 by $0.01. The business had revenue of $666.20 million during the quarter, compared to the consensus estimate of $667.39 million. Nu Skin Enterprises had a return on equity of 25.23% and a net margin of 5.68%. The business’s quarterly revenue was up 25.4% compared to the same quarter last year. During the same period in the previous year, the company posted $0.79 EPS. equities research analysts forecast that Nu Skin Enterprises, Inc. will post 3.56 EPS for the current fiscal year.
A number of equities analysts have weighed in on NUS shares. Zacks Investment Research lowered Nu Skin Enterprises from a “hold” rating to a “sell” rating in a research report on Wednesday, December 20th. ValuEngine raised Nu Skin Enterprises from a “hold” rating to a “buy” rating in a research report on Sunday, December 31st. Pivotal Research reissued a “buy” rating and issued a $90.00 target price on shares of Nu Skin Enterprises in a research report on Friday, February 16th. Deutsche Bank boosted their target price on Nu Skin Enterprises from $75.00 to $77.00 and gave the stock a “buy” rating in a research report on Friday, February 16th. Finally, Citigroup reissued a “buy” rating and issued a $81.00 target price (up previously from $70.00) on shares of Nu Skin Enterprises in a research report on Tuesday, January 23rd. Two equities research analysts have rated the stock with a sell rating, two have issued a hold rating and five have issued a buy rating to the stock. Nu Skin Enterprises currently has a consensus rating of “Hold” and an average price target of $71.29.
Several institutional investors have recently added to or reduced their stakes in NUS. Raymond James Financial Services Advisors Inc. bought a new stake in shares of Nu Skin Enterprises during the 3rd quarter valued at about $893,000. Crossmark Global Holdings Inc. bought a new stake in shares of Nu Skin Enterprises during the 3rd quarter valued at about $334,000. New York State Teachers Retirement System grew its stake in shares of Nu Skin Enterprises by 33.6% during the 3rd quarter. New York State Teachers Retirement System now owns 19,100 shares of the company’s stock valued at $1,174,000 after purchasing an additional 4,800 shares during the period. American Century Companies Inc. grew its stake in shares of Nu Skin Enterprises by 12.0% during the 3rd quarter. American Century Companies Inc. now owns 478,618 shares of the company’s stock valued at $29,425,000 after purchasing an additional 51,460 shares during the period. Finally, Prudential Financial Inc. grew its stake in shares of Nu Skin Enterprises by 826.4% during the 3rd quarter. Prudential Financial Inc. now owns 374,549 shares of the company’s stock valued at $23,027,000 after purchasing an additional 334,120 shares during the period. Institutional investors and hedge funds own 76.62% of the company’s stock.
ILLEGAL ACTIVITY NOTICE: “Insider Selling: Nu Skin Enterprises, Inc. (NUS) CFO Sells 724 Shares of Stock” was posted by American Banking News and is owned by of American Banking News. If you are reading this news story on another domain, it was stolen and republished in violation of U.S. & international trademark & copyright law. The original version of this news story can be read at https://www.americanbankingnews.com/2018/03/12/insider-selling-nu-skin-enterprises-inc-nus-cfo-sells-724-shares-of-stock.html.
Nu Skin Enterprises Company Profile
Nu Skin Enterprises, Inc is a direct selling company that develops and distributes personal care products and nutritional supplements, and a range of other products and services. The Company offers anti-aging personal care products and nutritional supplements under its Nu Skin and Pharmanex brands. The Nu Skin brand offers a range of products, including ageLOC Me customized skin care system, ageLOC Spa systems and ageLOC Transformation anti-aging skin care system.
Receive News & Ratings for Nu Skin Enterprises Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Nu Skin Enterprises and related companies with MarketBeat.com's FREE daily email newsletter.